These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 13865666)

  • 1. Classification of CNS drugs by a mouse screening battery.
    BASTIAN JW
    Arch Int Pharmacodyn Ther; 1961 Oct; 133():347-64. PubMed ID: 13865666
    [No Abstract]   [Full Text] [Related]  

  • 2. CNS drug specificity as determined by the mouse intravenous pentylenetetrazol technique.
    BASTIAN JW; KRAUSE WE; RIDLON SA; ERCOLI N
    J Pharmacol Exp Ther; 1959 Sep; 127():75-80. PubMed ID: 13797447
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of some central depressants on two simple reflexes in the mouse.
    WITKIN LB; SPITALETTA P; PLUMMER AJ
    J Pharmacol Exp Ther; 1959 Aug; 126():330-3. PubMed ID: 13845448
    [No Abstract]   [Full Text] [Related]  

  • 4. Some central nervous system drugs designed from metabolic considerations.
    PINSON R; BLOOM BM; BUCK CJ
    Ann N Y Acad Sci; 1962 Jan; 96():336-44. PubMed ID: 14486781
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of centrally acting drugs in mice with fighting behaviour induced by isolation.
    SCRIABINE A; BLAKE M
    Psychopharmacologia; 1962; 3():224-6. PubMed ID: 13910045
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of central nervous system drugs on the enzyme activity of rat brain.
    ALBAUM HG
    Proj Rep USAF Sch Aviat Med; 1960 Nov; 60(86):1-8. PubMed ID: 24545374
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of centrally acting drugs on the correlation of electrocortical activity and wakeful of cats.
    HOROVITZ ZP; CHOW MI
    J Pharmacol Exp Ther; 1962 Jul; 137():127-32. PubMed ID: 14448993
    [No Abstract]   [Full Text] [Related]  

  • 8. [Electrophysiological actions of stimulants of the central nervous system. I. Adrenergic, cholinergic systems and serotonic neurohumors].
    MONNIER M
    Arch Int Pharmacodyn Ther; 1960 Mar; 124():281-301. PubMed ID: 14423599
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preparations of Sterculia platanifolia: new stimulant].
    TRAKMAN IuG; CHERIKOVSKAIA TIa; PAPERINA TE
    Sov Med; 1959 Jun; 23():107-10. PubMed ID: 13839162
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological studies on a new central depressant 2-hydroxy 2-phenyl ethyl carbamate.
    DE SALVA SJ; CLEMENTS GR; ERCOLI N
    J Pharmacol Exp Ther; 1959 Aug; 126():318-22. PubMed ID: 13815015
    [No Abstract]   [Full Text] [Related]  

  • 11. A new series of central depressants: N-alkylaryl camphidines.
    HERMANSEN K
    Acta Pharmacol Toxicol (Copenh); 1960; 17():277-87. PubMed ID: 13713638
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of central nervous system agents on rat-brain gamma-aminobutyric acid level.
    FERRARI RA; ARNOLD A
    Biochim Biophys Acta; 1961 Sep; 52():361-7. PubMed ID: 13892506
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemistry and pharmacology of CNS depressants related to 4-(4-hydroxy-phenylpiperidino)butyrophenone. I. Synthesis and screening data in mice.
    JANSSEN PA; VAN DE WESTERINGH C; JAGENEAU AH; DEMOEN PJ; HERMANS BK; VAN DAELE GH; SCHELLEKENS KH; VAN DER EYCKEN CA
    J Med Pharm Chem; 1959 Jun; 1():281-97. PubMed ID: 14406750
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.
    Zhang YY; Liu H; Summerfield SG; Luscombe CN; Sahi J
    Mol Pharm; 2016 May; 13(5):1540-50. PubMed ID: 27015243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model.
    Doran A; Obach RS; Smith BJ; Hosea NA; Becker S; Callegari E; Chen C; Chen X; Choo E; Cianfrogna J; Cox LM; Gibbs JP; Gibbs MA; Hatch H; Hop CE; Kasman IN; Laperle J; Liu J; Liu X; Logman M; Maclin D; Nedza FM; Nelson F; Olson E; Rahematpura S; Raunig D; Rogers S; Schmidt K; Spracklin DK; Szewc M; Troutman M; Tseng E; Tu M; Van Deusen JW; Venkatakrishnan K; Walens G; Wang EQ; Wong D; Yasgar AS; Zhang C
    Drug Metab Dispos; 2005 Jan; 33(1):165-74. PubMed ID: 15502009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the subject of the permeability behavior of the CNS under the effect of reserpine and orphenadrine].
    LIEBALDT G
    Med Esp; 1960; 2():377-80. PubMed ID: 13761977
    [No Abstract]   [Full Text] [Related]  

  • 17. Electrographic and histologic changes produced in the central nervous system by topically applied sulfamethoxypyridazine and other antibacterial drugs.
    KEENER EB; PEROT PL
    Trans Am Neurol Assoc; 1960; 85():210-2. PubMed ID: 14454811
    [No Abstract]   [Full Text] [Related]  

  • 18. [Behavior changes in cats caused by different central stimulating drugs. 2].
    MUELLER-CALGAN H; HOTOVY R
    Arzneimittelforschung; 1961 Aug; 11():775-83. PubMed ID: 14476954
    [No Abstract]   [Full Text] [Related]  

  • 19. [A method for the injection of drugs into a limited area of the brain of the rabbit].
    AYALA GF
    Boll Soc Ital Biol Sper; 1962 Feb; 38():157-60. PubMed ID: 13863479
    [No Abstract]   [Full Text] [Related]  

  • 20. [Electrophysiological classification of central nervous system stimulants. II. Effect of hallucinogenic, psychotonic, analeptic on arousal and depressing mechanisms].
    MONNIER M; KRUPP P
    Arch Int Pharmacodyn Ther; 1960 Sep; 127():337-60. PubMed ID: 13772051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.